I3C and ICZ inhibit migration by suppressing the EMT process and FAK expression in breast cancer cells

Molecular Medicine Reports

Volumn 7, Issue 2, 2013, Pages 384-388

  Ho, Jin Nyoung ^a   Jun, Woojin ^b   Choue, Ryowon ^a   Lee, Jeongmin ^a  

^a Kyung Hee University   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

Epithelial to mesenchymal transition; Focal adhesion kinase; Indole 3 carbinol; Indole 3,2 b carbazole; Migration

Indexed keywords

3 INDOLEMETHANOL; ANTINEOPLASTIC AGENT; CARBAZOLE DERIVATIVE; FOCAL ADHESION KINASE; GELATINASE A; GELATINASE B; INDOLE[3,2 B]CARBAZOLE; MESSENGER RNA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL ASSAY; CELL MIGRATION; CELL STRAIN MCF 7; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; MIGRATION INHIBITION; PROTEIN EXPRESSION;

CADHERINS; CARBAZOLES; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; EPITHELIAL-MESENCHYMAL TRANSITION; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; INDOLES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MCF-7 CELLS; RNA, MESSENGER; VIMENTIN;

EID: 84873827829     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1198     Document Type: Article

References (36)

1. Jemal A, Center MM, De Santis C and Ward EM: Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19: 1893-1907, 2010.
2. Luo M and Guan JL: Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. Cancer Lett 289: 127-139, 2010.
3. Hsu YL, Wu LY, Hou MF, Tsai EM, Lee JN, Liang HL, Jong YJ, Hung CH and Kuo PL: Glabridin, an isoflavan from licorice root, inhibits migration, invasion and angiogenesis of MDA-MB-231 human breast adenocarcinoma cells by inhibiting focal adhesion kinase/Rho signaling pathway. Mol Nutr Food Res 55: 318-327, 2011.
4. Park SK, Kim Y, Kang D, Jung EJ and Yoo KY: Risk factors and control strategies for the rapidly rising rate of breast cancer in Korea. J Breast Cancer 14: 79-87, 2011.
5. Hay ED: The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 233: 706-720, 2005.
6. Huber MA, Kraut N and Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558, 2005.
7. Sarkar FH, Li Y, Wang Z and Kong D: Pancreatic cancer stem cells and EMT in drug resistance and metastasis. Minerva Chir 64: 489-500, 2009.
8. Hardy KM, Booth BW, Hendrix MJ, Salomon DS and Strizzi L: ErbB/EGF signaling and EMT in mammary development and breast cancer. J Mammary Gland Biol Neoplasia 15: 191-199, 2010.
9. Foroni C, Massimo B, Generali D and Damia G: Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. Cancer Treat Rev 38: 689-697, 2012.
10. Stetler-Stevenson WG, Aznavoorian S and Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9: 541-573, 1993.
11. Nabeshima K, Inoue T, Shimao Y and Sameshima T: Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol Int 52: 255-264, 2002.
12. Zhao J and Guan JL: Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev 28: 35-49, 2009.
13. van Nimwegen MJ and van de Water B: Focal adhesion kinase: a potential target in cancer therapy. Biochem Pharmacol 73: 597-609, 2007.
14. Cortes-Reynosa P, Robledo T, Macias-Silva M, Wu SV and Salazar EP: Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells. Matrix Biol 27: 220-231, 2008.
15. Chen PN, Chu SC, Kuo WH, Chou MY, Lin JK and Hsieh YS: Epigallocatechin-3 gallate inhibits invasion, epithelial-mesenchymal transition, and tumor growth in oral cancer cells. Agric Food Chem 59: 3836-3844, 2011.
16. Vergara D, Valente CM, Tinelli A, Siciliano C, Lorusso V, Acierno R, Giovinazzo G, Santino A, Storelli C and Maffia M: Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells. Cancer Lett 310: 1-8, 2011.
17. Meng Q, Goldberg ID, Rosen EM and Fan S: Inhibitory effects of Indole-3-carbinol on invasion and migration in human breast cancer cells. Breast Cancer Res Treat 63: 147-152, 2000.
18. Anderton MJ, Manson MM, Verschoyle RD, Gescher A, Lamb JH, Farmer PB, Steward WP and Williams ML: Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice. Clin Cancer Res 10: 5233-5241, 2004.
19. Liu H, Wormke M, Safe SH and Bjeldanes LF: Indolo[3, 2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity. J Natl Cancer Inst 86: 1758-1765, 1994.
20. Chen YH, Dai HJ and Chang HP: Suppression of inducible nitric oxide production by indole and isothiocyanate derivatives from Brassica plants in stimulated macrophages. Planta Med 69: 696-700, 2003.
21. Lauffenburger DA and Horwitz AF: Cell migration: a physically integrated molecular process. Cell 84: 359-369, 1996.
22. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT and Horwitz AR: Cell migration: integrating signals from front to back. Science 302: 1704-1709, 2003.
23. Guarino M, Rubino B and Ballabio G: The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39: 305-318, 2007.
24. Micalizzi DS, Farabaugh SM and Ford HL: Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 15: 117-134, 2010.
25. Lee JM, Dedhar S, Kalluri R and Thompson EW: The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172: 973-981, 2006.
26. Li T, Li YG and Pu DM: Matrix metalloproteinase-2 and -9 expression correlated with angiogenesis in human adenomyosis. Gynecol Obstet Invest 62: 229-235, 2006.
27. Hung WC and Chang HC: Indole-3-carbinol inhibits Sp1-induced matrix metalloproteinase-2 expression to attenuate migration and invasion of breast cancer cells. J Agric Food Chem 57: 76-82, 2009.
28. Radisky ES and Radisky DC: Matrix metalloproteinase-induced epithelial-mesecnchymal transition in breast cancer. J Mammary Gland Biol Neoplasia 15: 201-212, 2010.
29. Lin CY, Tsai PH, Kandaswami CC, Lee PP, Huang CJ, Hwang JJ and Lee MT: Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition. Cancer Sci 102: 815-827, 2011.
30. Cary LA, Chang JF and Guan JL: Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J Cell Sci 109: 1787-1794, 1996.
31. Zhao X and Guan JL: Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv Drug Deliv Rev 63: 610-615, 2011.
32. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M and Yamamoto T: Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377: 539-544, 1995.
33. Cicchini C, Laudadio I, Citarella F, Carazzari M, Steindler C, Conigliaro A, Fantoni A, Amicone L and Tripodi M: TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling. Exp Cell Res 314: 143-152, 2008.
34. Deng B, Yang X, Liu J, He F, Zhu Z and Zhang C: Focal adhesion kinase mediates TGF-beta1-induced renal tubular epithelial-to-mesenchymal transition in vitro. Mol Cell Biochem. 340: 21-29, 2010.
35. Bonnesen C, Eggleston IM and Hayes JD: Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res 61: 6120-6130, 2001.
36. Bradlow HL: Indole-3-carbinol as a chemoprotective agent in breast and prostate cancer. In Vivo 22: 441-445, 2008.